ODI Pharma moves the AGM and postpones the publication of Annual Report 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby hereby announces that the Company, due to administrative reasons, chooses to move the Annual General Meeting to a later date and also postpone the publication of the Annual Report for the financial year 2023/2024.The Annual General Meeting was originally scheduled to be held on December 13, 2024. Due to administrative reasons, ODI Pharma has chosen to postpone the AGM. The Company will issue a new notice for the AGM no later than four weeks before the new date. This also means that the publication of the annual report for the fiscal year 2023/